Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Starling Oncology, Inc.Security delisted | Other | $7.2K | SEC | ||
Starling Oncology, Inc.Security delisted | Other | $62.4K | Unusual size | SEC | |
Starling Oncology, Inc.Security delisted | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Starling Oncology, Inc.Security delisted | Other | $4.7K | SEC | ||
Starling Oncology, Inc.Security delisted | Other | $895.5 | SEC | ||
Starling Oncology, Inc.Security delisted | Sell | $879.3 | SEC | ||
Starling Oncology, Inc.Security delisted | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Starling Oncology, Inc.Security delisted | Other | $4.3K | Unusual size | SEC | |
Starling Oncology, Inc.Security delisted | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Starling Oncology, Inc.Security delisted | BuyD (derivative) | $588.6 | ClusterFirst in 12mo | SEC | |
Starling Oncology, Inc.Security delisted | Buy | $9.4K | conv 75ClusterFirst in 12mo | SEC | |
Starling Oncology, Inc.Security delisted | Other | $1K | SEC | ||
Starling Oncology, Inc.Security delisted | Other | $87.7 | SEC | ||
Starling Oncology, Inc.Security delisted | Other | $32.9 | SEC |